BrainGate Neural Interface System
BrainGate Neural Interface System is a medical device with 4 clinical trials. Currently 3 active trials ongoing.
Registry-listed formulations
This catalogue entry has no confirmed scientific concept.
Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.
1 source entries across 1 studies. This list may not include all unresolved or historical entries.
- BrainGate Neural Interface SystemRegistry intervention
Linked study entry; product equivalence not established
View study and source
Success Metrics
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Highest Phase Reached
UnknownTrial Status & Enrollment
0.0%
0 of 0 finished
0.0%
0 ended early
3
trials recruiting
4
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia (BG-Tablet-01)
BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Aphasia
Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia
Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia (BG-Speech-02)
Clinical Trials (4)
Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia (BG-Tablet-01)
BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Aphasia
Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia
Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia (BG-Speech-02)
All 4 trials loaded
Drug Details
- Intervention Type
- Device
- Total Trials
- 4